HEALTH● LOW4d ago · Oct 9, 2026, 3:54 PM
Johnson & Johnson says long-term data boosts Icotyde for plaque psoriasis
Seeking Alpha Tech · global
Johnson & Johnson has reported that long-term data supports the effectiveness of Icotyde for treating plaque psoriasis. This indicates a positive development for the drug in addressing a medical condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH34m agoPope Leo XIV recovering after lung cancer operationFrance 24 [en]HEALTH41m agoPope has peaceful night after lung cancer surgeryANSA [en]HEALTH49m agoPope has peaceful night after lung cancer surgeryANSA [en]HEALTH1h agoWarning about three risk factors that often go unnoticed and are a threat to the heartClarín